Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
TD Cowen has reaffirmed a Hold rating on eBay and left its $84 price target unchanged after updating its model through 2031. The firm expects double-digit revenue growth for the fourth quarter of 2025, supported by favorable foreign exchange effects and projected gross merchandise volume (GMV) gains, while other brokers offer divergent assessments …
TD Cowen maintained a Buy rating and a $255 price target on Palo Alto Networks following the company’s fiscal second-quarter 2026 results, citing healthy demand and AI-related momentum. The quarter showed 33% growth in next-generation security annual recurring revenue and 23% growth in remaining performance obligations, and the company reaffirmed f…
TD Cowen reduced its price target on QuantumScape to $8 from $16 and left the stock at a Hold rating, pointing to electric vehicle market headwinds that have pushed the company’s production ramp further into the future. The new target is marginally above the stock’s recent trading level of $7.20. The firm acknowledged QuantumScape's operational exe…
TD Cowen cut its price objective on General Mills to $45 from $47 while keeping a Hold rating, citing weak consumer sentiment that has slowed category growth and pushed consumers to time purchases around promotions. The adjustment comes as the company revises its fiscal 2026 outlook and faces underperformance across key categories, including Cereal…
Moleculin Biotech Inc.'s stock climbed 3.1% in premarket trading after the company released preliminary blinded results from its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin plus cytarabine in patients with acute myeloid leukemia (AML). Blinded data from the initial 30 subjects produced a composite complete remission rate of 40%, a figure …
Freshworks (FRSH) sold off sharply after conservative guidance, but the company still generates meaningful free cash flow, has double-digit revenue growth, and trades at a reasonable multiple to FCF and sales. With RSI in deeply oversold territory and short interest elevated, this is a tactical long for traders who want a defined-risk exposure to a…
Compass Point increased its price target on Affirm Holdings Inc. to $68 from $64 and kept a Buy rating after the company reported fiscal second-quarter fiscal 2026 results. The revision reflects updated estimates and a valuation anchored at 20 times Compass Point's fiscal 2027 adjusted EPS of $3.38. Multiple analysts also updated their ratings and …
Truist Securities reaffirmed its Buy rating on Walmart and kept a $127 price target, citing card-spend trends that indicate higher-income shoppers are increasingly using Walmart. The firm sees sales momentum consistent with its estimates and expects Walmart to guide toward roughly 3% to 4% sales growth through 2026; other sell-side firms have also …
Palo Alto Networks reported second-quarter fiscal 2026 results that topped internal guidance across revenue, margins and next-generation security (NGS) annual recurring revenue, prompting Truist Securities to reaffirm a Buy rating and a $200.00 price target. The target implies roughly 22% upside from a stated share price of $163.50 and aligns with …
A YouGov survey conducted with BVNK, Coinbase and Artemis finds Nigeria and South Africa leading growth in stablecoin holdings and optimism, with users seeking wider acceptance and integration into existing financial tools. Stablecoins remain primarily used for crypto trading, while central banks worry about dollarisation and capital flight.
Abu Dhabi's Mubadala Investment Co. and its unit, the Abu Dhabi Investment Council (ADIC), raised their holdings in BlackRock's iShares Bitcoin Trust ETF in the fourth quarter of 2025, increasing collective exposure to Bitcoin-linked assets even as Bitcoin and related ETFs suffered significant price declines.
Kraft Heinz has named Nicolas Amaya as president of its North America business, replacing Pedro Navio effective February 23. The move comes a week after the packaged food maker paused plans to split the company and announced fresh investments to shore up its U.S. operations, which have been facing persistent demand weakness. New CEO Steve Cahillane…
Barclays on Tuesday lowered its rating on Transocean to Equalweight from Overweight while increasing its price target to $6.00 from $4.50. The bank adjusted its valuation model - cutting the discount rate and raising EBITDA estimates for 2026 and 2027 - citing a stronger balance sheet after a recent equity raise and a cash tender offer. The researc…
Truist Securities trimmed its price target for Goosehead Insurance Inc. (GSHD) to $58 from $72 while retaining a Hold rating, citing a conservative margin outlook even as management projects double-digit revenue growth. The firm left its 2026 EPS estimate unchanged at $2.00 and sees mid-teens topline expansion through 2027, while other brokerages o…
BMO Capital increased its 12-month price target for PPL Corp to $41 from $40 and kept an Outperform rating after the Kentucky Public Service Commission modified aspects of the KU/LG&E rate case. The commission reduced the allowed return on equity and adjusted certain capital riders, modestly lowering the aggregate revenue increase. Separately, PPL …
Truist Securities cut its price objective for Waystar Holding to $38 from $51 and kept a Buy rating after updating its model and reducing the valuation multiple to 15x from 20x. The move follows a broader re-rating across software peers even as Waystar reported robust fourth-quarter 2025 results, reiterated strong 2026 guidance, and highlighted pro…
Barclays has cut Noble Corporation's stock rating to Equalweight from Overweight even as it raises the firm's price target to $41 from $36. The revision reflects concerns about the company's current valuation relative to the new rig-level discounted cash flow that now produces a larger enterprise value. Barclays also updated near-term EBITDA foreca…
Truist Securities reiterated a Buy rating and a $40.00 price target on Viridian Therapeutics (NASDAQ: VRDN) ahead of topline results from the REVEAL-1 trial of elegrobart. The firm highlighted physician acceptance of modest efficacy if paired with the convenience of a subcutaneous, half-life extended IGF-1Ra and expects a positive REVEAL-1 to lower…
European political leaders are expected to negotiate a package for the next set of European Central Bank appointments if Christine Lagarde leaves before her term ends, with former central bank chiefs Klaas Knot and Pablo Hernández de Cos emerging as principal contenders for senior roles. The potential arrangement would likely allocate top positions…
Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3.5% Wednesday following the announcement of HRD-RNA, a 1,660-gene logistic regression algorithm that evaluates Homologous Recombination Deficiency via tumor gene expression rather than DNA scarring. The algorithm is available for research use now, with clinical availability expected later this year. …
Citigroup has finalized the disposal of its former Russian unit, AO Citibank, transferring ownership to Renaissance Capital. The acquired bank will be renamed RenCap Bank and will function within the Renaissance Capital group while remaining a separate business unit and continuing to serve its traditional institutional clients. Both parties confirm…
Humain, a Saudi Arabia-backed artificial intelligence firm, has invested $3 billion in Elon Musk’s xAI, obtaining a significant minority stake just prior to xAI’s acquisition by SpaceX. Under the transaction terms, Humain’s interest in xAI will convert into SpaceX shares. The deal deepens collaboration between Humain and Musk’s companies and includ…
Citizens downgraded Workday from Market Outperform to Market Perform after founder Aneel Bhusri announced his return as chief executive and the company preannounced fourth-quarter results that were in line with guidance. The brokerage praised Bhusri’s background but warned the transition could require time and investment, and highlighted intensifyi…
Unnatural Products has entered a licensing agreement with Novartis to advance macrocyclic peptide therapies targeting a cardiovascular program. The California-based company will receive an upfront payment and is eligible for substantial milestone payments and tiered royalties, while Novartis will manage clinical development, manufacturing and globa…
Mizuho raised its price objective on Orion Engineered Carbons S.A. (OEC) to $5.25 from $4.50 while retaining an Underperform rating, attributing the target increase to higher market multiples. Orion shares trade at $5.74, inside a 52-week range of $4.34 to $16.63, and InvestingPro Fair Value metrics still indicate the stock may be undervalued. The …
